ATX amplia therapeutics limited

Ann: Encouraging Updated Data from Pancreatic Cancer Trial, page-5

  1. 669 Posts.
    lightbulb Created with Sketch. 260
    There really is bugger all interest in this!
    •••••they’ve done well recruiting ahead of schedule too, most companies underperform with recruitment timelines.
    ••••Encouraging results but be careful reading too much into the claim if they see at least 15 pRs it means the narma combo is outperforming chemo alone. I know what they’re saying, PR rate with gem + abrax was 23% in the MPACT phase 3, if ATX get 15 it’s 15/55 which = 27%. Unfortunately that’s not a valid comparison , sample 55 plays 430, too much error, the confidence intervals will show why. They won’t say that at the AACR. But still, pretty good results, nice effort.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
22.0¢
Change
0.025(12.8%)
Mkt cap ! $85.34M
Open High Low Value Volume
19.0¢ 22.5¢ 19.0¢ $939.8K 4.509M

Buyers (Bids)

No. Vol. Price($)
1 100000 21.5¢
 

Sellers (Offers)

Price($) Vol. No.
22.0¢ 61514 1
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.